What is the recommended dose of Cephalexin (Cefalexin) for the treatment of cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Dosing for Cellulitis

For adult patients with cellulitis, the recommended dose of cephalexin is 500 mg four times daily (every 6 hours) for 5-7 days. 1, 2

Adult Dosing Regimen

  • Standard oral regimen: 500 mg every 6 hours (2 g total daily dose) 1, 3
  • Duration: 5 days is typically sufficient if clinical improvement occurs, though treatment may be extended if infection has not adequately improved 1, 3
  • For more severe infections, doses up to 4 g daily may be considered 2

Pediatric Dosing Regimen

  • Standard dose: 75-100 mg/kg/day divided into 3-4 doses 2
  • For typical skin infections: 25-50 mg/kg/day divided into 4 doses 2
  • For severe infections, dosage may be doubled 2

Clinical Decision Algorithm

  1. Assess severity and type of cellulitis:

    • For typical non-purulent cellulitis without systemic signs: oral cephalexin is appropriate 1, 3
    • For purulent cellulitis or evidence of abscess: consider additional MRSA coverage 3
    • For severe infection with systemic signs: consider intravenous therapy 3
  2. Determine appropriate duration:

    • Start with 5-day course 1, 3
    • Extend treatment if no clinical improvement by day 5 1
    • Continue therapy until 3 days after the infection appears cured 4
  3. Consider adjunctive measures:

    • Elevation of affected area to promote drainage of edema 3
    • Treatment of predisposing conditions (tinea pedis, venous insufficiency) 3, 1
    • For non-diabetic adults, systemic corticosteroids may be considered (prednisone 40 mg daily for 7 days) 3, 1

Evidence Strength and Considerations

  • MRSA is an unusual cause of typical cellulitis - β-lactam monotherapy with cephalexin is appropriate in the absence of abscess, ulcer, or purulent drainage 1, 3
  • Recent randomized trials show that adding trimethoprim-sulfamethoxazole (for MRSA coverage) to cephalexin does not significantly improve outcomes for uncomplicated cellulitis 4, 5
  • A recent pilot study suggests high-dose cephalexin (1000 mg four times daily) may reduce treatment failure compared to standard dosing (500 mg four times daily), though with more minor adverse effects 6
  • Adding anti-inflammatory therapy (such as ibuprofen) to antibiotic treatment may hasten resolution of cellulitis-related inflammation 7

Common Pitfalls to Avoid

  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors for MRSA 1, 3
  • Don't extend treatment unnecessarily beyond 5-7 days if clinical improvement has occurred 1, 3
  • Don't overlook examining interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence 1
  • Don't forget to consider hospitalization if there is concern for deeper infection, poor adherence to therapy, immunocompromise, or if outpatient treatment is failing 1

Special Situations

  • For cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, or injection drug use: consider adding MRSA coverage 1, 3
  • For recurrent cellulitis: address predisposing factors and consider prophylactic antibiotics for patients with 3-4 episodes per year 3
  • For penicillin-allergic patients (except those with immediate hypersensitivity reactions), cephalexin remains an option 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.